193 related articles for article (PubMed ID: 29794239)
1. Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project.
Schmainda KM; Prah MA; Rand SD; Liu Y; Logan B; Muzi M; Rane SD; Da X; Yen YF; Kalpathy-Cramer J; Chenevert TL; Hoff B; Ross B; Cao Y; Aryal MP; Erickson B; Korfiatis P; Dondlinger T; Bell L; Hu L; Kinahan PE; Quarles CC
AJNR Am J Neuroradiol; 2018 Jun; 39(6):1008-1016. PubMed ID: 29794239
[TBL] [Abstract][Full Text] [Related]
2. Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low-Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors.
Schmainda KM; Prah MA; Hu LS; Quarles CC; Semmineh N; Rand SD; Connelly JM; Anderies B; Zhou Y; Liu Y; Logan B; Stokes A; Baird G; Boxerman JL
AJNR Am J Neuroradiol; 2019 Apr; 40(4):626-633. PubMed ID: 30923088
[TBL] [Abstract][Full Text] [Related]
3. Performance of Standardized Relative CBV for Quantifying Regional Histologic Tumor Burden in Recurrent High-Grade Glioma: Comparison against Normalized Relative CBV Using Image-Localized Stereotactic Biopsies.
Hoxworth JM; Eschbacher JM; Gonzales AC; Singleton KW; Leon GD; Smith KA; Stokes AM; Zhou Y; Mazza GL; Porter AB; Mrugala MM; Zimmerman RS; Bendok BR; Patra DP; Krishna C; Boxerman JL; Baxter LC; Swanson KR; Quarles CC; Schmainda KM; Hu LS
AJNR Am J Neuroradiol; 2020 Mar; 41(3):408-415. PubMed ID: 32165359
[TBL] [Abstract][Full Text] [Related]
4. Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma.
Lee MD; Baird GL; Bell LC; Quarles CC; Boxerman JL
AJNR Am J Neuroradiol; 2019 Sep; 40(9):1445-1450. PubMed ID: 31371360
[TBL] [Abstract][Full Text] [Related]
5. Arterial Spin-Labeling and DSC Perfusion Metrics Improve Agreement in Neuroradiologists' Clinical Interpretations of Posttreatment High-Grade Glioma Surveillance MR Imaging-An Institutional Experience.
Yamin G; Tranvinh E; Lanzman BA; Tong E; Hashmi SS; Patel CB; Iv M
AJNR Am J Neuroradiol; 2024 Apr; 45(4):453-460. PubMed ID: 38453410
[TBL] [Abstract][Full Text] [Related]
6. Effects of MRI Protocol Parameters, Preload Injection Dose, Fractionation Strategies, and Leakage Correction Algorithms on the Fidelity of Dynamic-Susceptibility Contrast MRI Estimates of Relative Cerebral Blood Volume in Gliomas.
Leu K; Boxerman JL; Ellingson BM
AJNR Am J Neuroradiol; 2017 Mar; 38(3):478-484. PubMed ID: 28034995
[TBL] [Abstract][Full Text] [Related]
7. Optimization of Acquisition and Analysis Methods for Clinical Dynamic Susceptibility Contrast MRI Using a Population-Based Digital Reference Object.
Semmineh NB; Bell LC; Stokes AM; Hu LS; Boxerman JL; Quarles CC
AJNR Am J Neuroradiol; 2018 Nov; 39(11):1981-1988. PubMed ID: 30309842
[TBL] [Abstract][Full Text] [Related]
8. Optimization of DSC MRI Echo Times for CBV Measurements Using Error Analysis in a Pilot Study of High-Grade Gliomas.
Bell LC; Does MD; Stokes AM; Baxter LC; Schmainda KM; Dueck AC; Quarles CC
AJNR Am J Neuroradiol; 2017 Sep; 38(9):1710-1715. PubMed ID: 28684456
[TBL] [Abstract][Full Text] [Related]
9. Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.
Hu LS; Kelm Z; Korfiatis P; Dueck AC; Elrod C; Ellingson BM; Kaufmann TJ; Eschbacher JM; Karis JP; Smith K; Nakaji P; Brinkman D; Pafundi D; Baxter LC; Erickson BJ
AJNR Am J Neuroradiol; 2015 Dec; 36(12):2242-9. PubMed ID: 26359151
[TBL] [Abstract][Full Text] [Related]
10. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
[TBL] [Abstract][Full Text] [Related]
11. Improved Leakage Correction for Single-Echo Dynamic Susceptibility Contrast Perfusion MRI Estimates of Relative Cerebral Blood Volume in High-Grade Gliomas by Accounting for Bidirectional Contrast Agent Exchange.
Leu K; Boxerman JL; Cloughesy TF; Lai A; Nghiemphu PL; Liau LM; Pope WB; Ellingson BM
AJNR Am J Neuroradiol; 2016 Aug; 37(8):1440-6. PubMed ID: 27079371
[TBL] [Abstract][Full Text] [Related]
12. Analysis of postprocessing steps for residue function dependent dynamic susceptibility contrast (DSC)-MRI biomarkers and their clinical impact on glioma grading for both 1.5 and 3T.
Bell LC; Stokes AM; Quarles CC
J Magn Reson Imaging; 2020 Feb; 51(2):547-553. PubMed ID: 31206948
[TBL] [Abstract][Full Text] [Related]
13. Perfusion MR imaging of enhancing brain tumors: Comparison of arterial spin labeling technique with dynamic susceptibility contrast technique.
Soni N; Dhanota DPS; Kumar S; Jaiswal AK; Srivastava AK
Neurol India; 2017; 65(5):1046-1052. PubMed ID: 28879895
[TBL] [Abstract][Full Text] [Related]
14. Intravoxel incoherent motion diffusion-weighted imaging analysis of diffusion and microperfusion in grading gliomas and comparison with arterial spin labeling for evaluation of tumor perfusion.
Shen N; Zhao L; Jiang J; Jiang R; Su C; Zhang S; Tang X; Zhu W
J Magn Reson Imaging; 2016 Sep; 44(3):620-32. PubMed ID: 26880230
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of pulsed-continuous arterial spin labeling and dynamic susceptibility contrast imaging by histogram analysis in evaluation of glial tumors.
Arisawa A; Watanabe Y; Tanaka H; Takahashi H; Matsuo C; Fujiwara T; Fujiwara M; Fujimoto Y; Tomiyama N
Neuroradiology; 2018 Jun; 60(6):599-608. PubMed ID: 29705876
[TBL] [Abstract][Full Text] [Related]
16. Association between Tumor Acidity and Hypervascularity in Human Gliomas Using pH-Weighted Amine Chemical Exchange Saturation Transfer Echo-Planar Imaging and Dynamic Susceptibility Contrast Perfusion MRI at 3T.
Wang YL; Yao J; Chakhoyan A; Raymond C; Salamon N; Liau LM; Nghiemphu PL; Lai A; Pope WB; Nguyen N; Ji M; Cloughesy TF; Ellingson BM
AJNR Am J Neuroradiol; 2019 Jun; 40(6):979-986. PubMed ID: 31097430
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas.
Nguyen TB; Cron GO; Bezzina K; Perdrizet K; Torres CH; Chakraborty S; Woulfe J; Jansen GH; Thornhill RE; Zanette B; Cameron IG
AJNR Am J Neuroradiol; 2016 Dec; 37(12):2217-2223. PubMed ID: 27585700
[TBL] [Abstract][Full Text] [Related]
18. Assessment of brain tumors by magnetic resonance dynamic susceptibility contrast perfusion-weighted imaging and computed tomography perfusion: a comparison study.
Scola E; Desideri I; Bianchi A; Gadda D; Busto G; Fiorenza A; Amadori T; Mancini S; Miele V; Fainardi E
Radiol Med; 2022 Jun; 127(6):664-672. PubMed ID: 35441970
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Different Post-Processing Algorithms for Dynamic Susceptibility Contrast Perfusion Imaging of Cerebral Gliomas.
Kudo K; Uwano I; Hirai T; Murakami R; Nakamura H; Fujima N; Yamashita F; Goodwin J; Higuchi S; Sasaki M
Magn Reson Med Sci; 2017 Apr; 16(2):129-136. PubMed ID: 27646457
[TBL] [Abstract][Full Text] [Related]
20. Discrimination between Glioblastoma and Solitary Brain Metastasis: Comparison of Inflow-Based Vascular-Space-Occupancy and Dynamic Susceptibility Contrast MR Imaging.
Li X; Wang D; Liao S; Guo L; Xiao X; Liu X; Xu Y; Hua J; Pillai JJ; Wu Y
AJNR Am J Neuroradiol; 2020 Apr; 41(4):583-590. PubMed ID: 32139428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]